Initial severity of major depression and efficacy of new generation antidepressants: individual participant data meta‐analysis
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Objective: The role of baseline severity as effect modifier in various psychiatric disorders is a topic of controversy and of clinical import. This study aims to examine whether baseline severity modifies the efficacy of various antidepressants for major depression through individual participant data (IPD) meta‐analysis. Method: We identified all placebo‐controlled, double‐blind randomised trials of new generation antidepressants in the acute phase treatment of major depression conducted in Japan and requested their IPD through the public–private partnerships (PPP s) between the relevant academic societies and the pharmaceutical companies. The effect modification by baseline depression severity was examined through six increasingly complex competing mixed‐effects models for repeated measures. Results: We identified eleven eligible trials and obtained IPD from six, which compared duloxetine, escitalopram, mirtazapine, paroxetine or bupropion against placebo (total n = 2464). The best‐fitting model revealed that the interaction between baseline severity and treatment was not statistically significant (coefficient = −0.04, 95% confidence interval: −0.16 to 0.08, P = 0.49). Several sensitivity analyses confirmed the robustness of the findings. Conclusion: We may expect as much benefit from antidepressant treatments for mild, moderate or severe major depression. Clinical practice guidelines will need to take these findings into consideration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A New Initiative on Precision Medicine
Collins, F. S., & Varmus, H. (2015) · New England Journal of Medicine · doi:10.1056/nejmp1500523 · Cited by 5,202
Cipriani, A., Furukawa, T. A., Salanti, G., Chaimani, A., Atkinson, L. Z., Ogawa, Y., Leucht, S., Ruhe, H. G., Turner, E. H., Higgins, J. P. T., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)32802-7 · Cited by 3,541
Self-citationStewart, L. A., Clarke, M., Rovers, M., Riley, R. D., Simmonds, M., Stewart, G., & Tierney, J. F. (2015) · JAMA · doi:10.1001/jama.2015.3656 · Cited by 2,134 · cited 1×
“The reporting follows the PRISMA extension guideline for individual participant data meta-analysis (15).”
MethodAntidepressant Drug Effects and Depression Severity: A Patient-Level Meta-analysis
Fournier, J. C., DeRubeis, R. J., Hollon, S. D., Dimidjian, S., Amsterdam, J. D., Shelton, R. C., & Fawcett, J. (2010) · JAMA · doi:10.1001/jama.2009.1943 · Cited by 2,009
The prevention and treatment of missing data in clinical trials
Little, R. J., D'Agostino, R., Cohen, M. L., Dickersin, K., Emerson, S. S., Farrar, J. T., Frangakis, C., Hogan, J. W., Molenberghs, G., Murphy, S. A., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmsr1203730 · Cited by 1,884 · cited 1×
“Unfortunately, however, three of these four studies (8, 9, 11) used last-observation-carried-forward data, a method no longer considered to be appropriate for handling missing data (12).”
BackgroundBower, P., Kontopantelis, E., Sutton, A., Kendrick, T., Richards, D. A., Gilbody, S., Knowles, S., Cuijpers, P., Andersson, G., Christensen, H., et al. (2013) · BMJ · doi:10.1136/bmj.f540 · Cited by 341
Gibbons, R. D., Hur, K., Brown, C. H., Davis, J. M., & Mann, J. J. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.2044 · Cited by 271 · cited 4×
“(10), it must be emphasised that both of the analyses with higher methodological rigour in accounting for missing data through the mixed-effects models concluded that there was no appreciable influence of baseline depression severity on the efficacy of various antidepressants over placebo.”
BackgroundMethodInfluentialTimmerby, N., Andersen, J. H., Søndergaard, S., Østergaard, S. D., & Bech, P. (2017) · Psychotherapy and Psychosomatics · doi:10.1159/000457131 · Cited by 134
Furukawa, T. A., Weitz, E. S., Tanaka, S., Hollon, S. D., Hofmann, S. G., Andersson, G., Twisk, J., DeRubeis, R. J., Dimidjian, S., Hegerl, U., et al. (2017) · British Journal of Psychiatry · doi:10.1192/bjp.bp.116.187773 · Cited by 73 · cited 5×
“Furukawa et al. (35) analysed IPD of all randomised trials comparing CBT against pill placebo and found that baseline depression severity did not influence the difference in changes in depression scores between CBT and pill placebo.”
BackgroundMethodInfluentialSelf-citation
Cited by
Placebo effect in the treatment of depression and anxiety
Kirsch, I. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00407 · Cited by 205
Should antidepressants be used for major depressive disorder?
Jakobsen, J. C., Gluud, C., & Kirsch, I. (2020) · BMJ Evidence-Based Medicine · doi:10.1136/bmjebm-2019-111238 · Cited by 162
Lewis, G., Duffy, L., Ades, A., Amos, R., Araya, R., Brabyn, S., Button, K. S., Churchill, R., Derrick, C., Dowrick, C., et al. (2019) · The Lancet Psychiatry · doi:10.1016/s2215-0366(19)30366-9 · Cited by 120
Hieronymus, F., Lisinski, A., Nilsson, S., & Eriksson, E. (2019) · The Lancet Psychiatry · doi:10.1016/s2215-0366(19)30216-0 · Cited by 73
Horowitz, M., & Wilcock, M. (2022) · Drug and Therapeutics Bulletin · doi:10.1136/dtb.2020.000080 · Cited by 33
Metadata
- Authors
- Furukawa, T. A., Maruo, K., Noma, H., Tanaka, S., Imai, H., Shinohara, K., Ikeda, K., Yamawaki, S., Levine, S. Z., Goldberg, Y., Leucht, S., & Cipriani, A.
- Venue
- Acta Psychiatrica Scandinavica
- Publisher
- Wiley
- Published
- 2018-04-03
- Volume
- 137
- Issue
- 6
- Pages
- 450-458
- ISSN
- 0001-690X (ISSN-L)
- 1600-0447
- OpenAlex
- W2795956833
- Cited by
- 59
- References
- 9
- FWCI
- 4.33
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.